<unk>  is indicated for the treatment of people with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.
Voretigene neparvovec
Vibegron
Ofranergene obadenovec
Mestranol/noretynodrel
Enadenotucirev
Seviteronel
Crofelemer
Telotristat ethyl